Barriers to participation in randomised controlled trials: A systematic review

被引:688
作者
Ross, S
Grant, A
Counsell, C
Gillespie, W
Russell, I
Prescott, R
机构
[1] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland
[2] Western Gen Hosp, Cochrane Stroke Review Grp, Edinburgh EH4 2XU, Midlothian, Scotland
[3] Univ Edinburgh, Dept Orthopaed Surg, Edinburgh EH8 9YL, Midlothian, Scotland
[4] Univ York, Dept Hlth Sci & Clin Evaluat, York YO1 5DD, N Yorkshire, England
[5] Univ Edinburgh, Med Stat Unit, Edinburgh, Midlothian, Scotland
基金
英国惠康基金;
关键词
systematic review; randomised controlled trials; patient participation; clinician participation; barriers to participation;
D O I
10.1016/S0895-4356(99)00141-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Method: A systematic review of three bibliographic databases from 1986 to 1996 identified 78 papers reporting barriers to recruitment of clinicians and patients to randomised controlled trials. Results: Clinician barriers included: time constraints, lack of staff and training, worry about the impact on the doctor-patient relationship, concern for patients, loss of professional autonomy, difficulty with the consent procedure, lack of rewards and recognition, and an insufficiently interesting question. Patient barriers included: additional demands of the trial, patient preferences, worry caused by uncertainty, and concerns about information and consent. Conclusions: To overcome barriers to clinician recruitment, the trial should address an important research question and the protocol and data collection should be as straightforward as possible. The demands on clinicians and patients should be kept to a minimum. Dedicated research staff may be required to support clinical staff and patients. The recruitment aspects of a randomised controlled trial should be carefully planned and piloted. Further work is needed to quantify the extent of problems associated with clinician and patient participation, and proper evaluation is required of strategies to overcome barriers. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:1143 / 1156
页数:14
相关论文
共 89 条
[81]   EFFECTS OF 2 FORMATS OF INFORMED CONSENT ON KNOWLEDGE AMONGST PERSONS WITH ADVANCED HIV-DISEASE IN A CLINICAL-TRIAL OF DIDANOSINE [J].
TINDALL, B ;
FORDE, S ;
ROSS, MW ;
GOLDSTEIN, D ;
BARKER, S ;
COOPER, DA .
PATIENT EDUCATION AND COUNSELING, 1994, 24 (03) :261-266
[82]   RANDOMIZED CLINICAL-TRIALS IN GENERAL-PRACTICE - LESSONS FROM A FAILURE [J].
TOGNONI, G ;
ALLI, C ;
AVANZINI, F ;
BETTELLI, G ;
COLOMBO, F ;
CORSO, R ;
MARCHIOLI, R ;
ZUSSINO, A .
BRITISH MEDICAL JOURNAL, 1991, 303 (6808) :969-971
[83]  
Wadland W C, 1990, Fam Med, V22, P201
[84]  
Wilcox M, 1994, J Vasc Nurs, V12, P112
[85]   INFORMED CONSENT IN EUROPEAN MULTICENTER RANDOMIZED CLINICAL-TRIALS - ARE PATIENTS REALLY INFORMED [J].
WILLIAMS, CJ ;
ZWITTER, M .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (07) :907-910
[86]  
WINGERSON D, 1993, J CLIN PSYCHOPHARM, V13, P194
[87]  
Winn R J, 1984, Prog Clin Biol Res, V156, P63
[88]  
YEOMANSKINNEY A, 1995, CANCER-AM CANCER SOC, V76, P46, DOI 10.1002/1097-0142(19950701)76:1<46::AID-CNCR2820760107>3.0.CO
[89]  
2-B